Why Global Life Sciences Leaders See Automation as a Top Priority

For life sciences organizations today, COVID-19 and an increasingly complex regulatory landscape are spurring an urgent need to launch new applications–fast. Yet a number of challenges stand in the way, including complex business processes, concerns about data security and integrity, and even just knowing where to begin on the right tech solution to put in place.

Accelerating processes and progress

In a recent survey1, more than two thirds of life sciences organizations reported digital transformation initiatives to improve their processes and make their operations more efficient. Yet the journey has not been easy. Survey respondents said they are challenged by system complexity, manual operations and customization, as well as overarching concerns about speed to market and keeping up with new technologies.

Automation, in particular low-code automation, can address these challenges and more, particularly when delivered through a full stack that includes artificial intelligence, analytics, machine learning, and robotic process automation. Already low-code automation is showing results for streamlined regulatory management, handling change control requests, and much more for leading global life sciences organizations.

Closing the low-code automation gap

Yet less than half of survey respondents said they currently use automation. How can more life sciences organizations recognize the benefits of low-code automation? What steps can they take to get the process started?

See more survey highlights here, and learn more about using low-code automation to launch new applications and accelerate digital modernization. Email me at Evi.Cohen@appian.com to set up a time to talk.

___________________

1PharmaIntelligence Informa Survey, “Digital Transformation & the Life Sciences Industry,“ 2020

SUBSCRIBE TO APPIAN WEEKLY!